Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1945 studies found for:    Lipid Storage Diseases
Show Display Options
Rank Status Study
21 Completed Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia
Condition: Lipid Metabolism Disorder
Intervention: Drug: ezetimibe
22 Completed Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis
Conditions: Lipid Metabolism Disorders;   Sterols;   Diet, High-Fat;   Cholesterol;   Fatty Acids;   Hyperlipidemias
Interventions: Behavioral: Changes in cholesterol metabolism;   Other: Lean red meat diet;   Other: Fat red meat diet
23 Completed
Has Results
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Intervention: Drug: mipomersen sodium
24 Completed An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Intervention: Drug: mipomersen sodium
25 Completed
Has Results
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Interventions: Drug: mipomersen;   Drug: Placebo
26 Completed Regulation of Lipoprotein Transport in Metabolic Syndrome
Conditions: Obesity;   Lipid Disorders;   Cardiovascular Disease
Interventions: Drug: GW501516;   Drug: placebo pill
27 Recruiting The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study
Condition: Lipid Metabolism Disorders
Interventions: Dietary Supplement: Artichoke Leaf Extract;   Other: Placebo
28 Completed Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
Conditions: Lipid Metabolism, Inborn Errors;   Hyperlipidemias;   Metabolic Diseases;   Hypolipoproteinemia;   Hypolipoproteinemias;   Hypobetalipoproteinemias;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Congenital Abnormalities;   Metabolic Disorder;   Hypercholesterolemia;   Dyslipidemias;   Lipid Metabolism Disorders
Interventions: Drug: ISIS 301012 (mipomersen)  sodium;   Drug: Placebo;   Drug: ISIS 301012 (mipomersen) sodium;   Drug: placebo;   Drug: ISIS 301012 (mipomersen)   sodium
29 Completed A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 in Subjects With Hypercholesterolemia
Conditions: Hypercholesterolemia;   Dyslipidemias;   Hyperlipidemias;   Lipid Metabolism Disorders;   Metabolic Diseases
Intervention: Biological: PF-04950615
30 Recruiting Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 Years
Conditions: Vascular System Injuries;   Lipid Metabolism Disorders;   Endothelial Disfunction
Interventions: Drug: Resveratrol;   Behavioral: Caloric restriction
31 Completed
Has Results
Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects
Conditions: Metabolic Diseases;   Hyperlipidemias;   Metabolic Disorder;   Hypercholesterolemia;   Dyslipidemias;   Lipid Metabolism Disorders
Interventions: Drug: mipomersen;   Drug: placebo
32 Recruiting Alpha-linolenic Acid and Blood Pressure
Conditions: Hypertension;   Lipid Metabolism Disorders
Interventions: Dietary Supplement: Flaxseed oil;   Dietary Supplement: high oleic sunflower oil (HOSF)
33 Active, not recruiting Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
Conditions: Hyperlipidemias;   Hypertriglyceridemia;   Dyslipidemias;   Lipid Metabolism Disorders;   Metabolic Diseases
Interventions: Drug: CAT-2003;   Drug: Placebo
34 Completed Multiple Treatment Study
Condition: Body Fat Disorder
Intervention: Device: The Zeltiq System
35 Recruiting Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
Conditions: Mucopolysaccharidosis;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux-Lamy Syndrome;   Sly Syndrome;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy (ALD);   Krabbe Disease;   Metachromatic Leukodystrophy (MLD);   Sphingolipidoses;   Peroxisomal Disorders
Interventions: Drug: Campath-1H;   Drug: Cyclophosphamide;   Drug: Busulfan;   Procedure: Allogeneic stem cell transplantation;   Drug: Cyclosporine A;   Drug: Mycophenolate Mofetil
36 Active, not recruiting Outer Thigh Study With Varied Treatment Parameters
Condition: Body Fat Disorder
Intervention: Device: The Zeltiq System
37 Completed Pilot Study on The Flanks of Asian Patients
Condition: Body Fat Disorder
Intervention: Device: The Zeltiq System
38 Completed Clinical Test for Transtek Glass Body Analyzer
Conditions: Weight;   Body Fat Disorder;   Bone Mass
Intervention: Device: Comparison test
39 Completed Clinical Trail of Transtek Glass Body Fat Analyzer
Conditions: Weight;   Body Fat Disorder;   Bone Mass
Intervention: Device: Comparison test
40 Completed Feasibility Study of a Belt Applicator
Condition: Body Fat Disorder
Intervention: Device: The Zeltiq System

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years